European Journal of Histochemistry (ISSN: 1121-760X; E-ISSN: 2038-8306) is a distinguished peer-reviewed scholarly journal published by PAGEPRESS PUBL based in Italy. Since its inception in 1992 and with a commitment to Open Access since 2010, the journal has played a pivotal role in disseminating high-quality research in the fields of Histology, Biophysics, and Cell Biology. As of 2023, the journal holds a commendable position within the academic community, achieving Q2 rankings in Biophysics, Histology, and Medicine (miscellaneous), further highlighting its relevance and impact in these critical areas of research. Despite its HIndex not being specified, its Scopus rankings demonstrate the journal's competitive edge, particularly in Histology (Rank #33/62) and Biophysics (Rank #84/152). The journal aims to provide a platform for researchers to share innovative findings and contribute to the enrichment of knowledge in histochemical methodologies and their application to biomedical sciences. Its Open Access model ensures the broadest possible dissemination of research, making it an essential resource for researchers, professionals, and students alike who are engaged in the life sciences. For more information, visit the journal's webpage hosted by PAGEPRESS PUBL.

DEVELOPMENT is a preeminent journal published by COMPANY BIOLOGISTS LTD, headquartered in the United Kingdom. With an ISSN of 0950-1991 and an E-ISSN of 1477-9129, this esteemed journal has been at the forefront of the fields of Developmental Biology and Molecular Biology since its inception in 1987. Recognized for its rigorous peer review process and high-caliber research, DEVELOPMENT holds an impressive Q1 ranking in both disciplines as of 2023, underscoring its pivotal role in advancing scientific understanding. The journal is particularly noted for its contributions to the understanding of developmental processes, their molecular underpinnings, and their implications in health and disease. With a significant impact factor, DEVELOPMENT aims to disseminate groundbreaking research that inspires novel insights and future explorations within the biological sciences, making it an essential resource for researchers, professionals, and students alike. The journal also maintains accessibility for its readership, ensuring that significant research findings reach those who can apply and build upon them.

ACTA HISTOCHEMICA, a prestigious journal published by Elsevier GmbH, is dedicated to advancing the field of histochemistry and its applications within cell biology and medicine. With an ISSN of 0065-1281 and an E-ISSN of 1618-0372, the journal provides a critical platform for the dissemination of high-quality research findings and reviews, integral for both emerging and established scholars. Since its inception in 1954 and continuing through to 2024, ACTA HISTOCHEMICA has maintained a strong commitment to publishing significant advancements in histology and cell biology, as evidenced by its categorization in Q3 for Cell Biology and Histology, as well as Q2 in miscellaneous medicine for the year 2023. The journal ranks favorably in Scopus, holding the 27th rank in Histology and a 200th rank in Cell Biology, highlighting its importance to the academic community. With its headquarters in Munich, Germany, ACTA HISTOCHEMICA continues to attract contributions from global researchers, fostering an international dialogue essential for the growth of knowledge in histochemistry and related disciplines.

Regenerative Medicine, published by Taylor & Francis Ltd, is a pivotal journal within the field of biomedical research, focusing on the innovative advances in regenerative and restored functions in human health. With an ISSN of 1746-0751 and an E-ISSN of 1746-076X, this esteemed journal boasts a commendable impact factor within its categories, notably holding the Q2 status in Embryology and Q3 in Biomedical Engineering as of 2023. Covering a broad spectrum of topics from stem cell research to tissue engineering, it serves as a crucial platform for interdisciplinary collaboration among researchers, professionals, and students dedicated to the regeneration of tissues and organs. Given its comprehensive scope from 2006 to 2024, the journal continues to attract high-quality manuscripts that advance the frontiers of knowledge in regenerative medicine. Researchers and practitioners alike are encouraged to engage with the latest findings and methodologies disseminated in this vital publication.

CELL AND TISSUE RESEARCH, published by Springer, is a premier journal dedicated to advancing the field of cell biology, histology, pathology, and forensic medicine. With a proud history dating back to its foundation in 1924 and continuing its legacy, this journal has established itself as a vital source for innovative research, facilitating the dissemination of significant findings that contribute to the understanding of cellular and tissue dynamics. Hailing from Germany, the journal exhibits an impressive standing in the academic community with a 2023 impact factor reflected in its category quartiles: Q2 in Cell Biology, Q1 in Histology, and Q1 in Pathology and Forensic Medicine. It ranks notably within multiple Scopus categories, including 32/208 in Pathology and Forensic Medicine and 13/62 in Histology, showcasing its high percentile rankings of 84th and 79th, respectively. Researchers, professionals, and students benefit from its extensive coverage and rigorous peer-review process that ensures the integrity and relevance of its published works, thus making it an essential resource in the scientific community. While it operates under a subscription model, its commitment to quality and impact makes it an indispensable journal for anyone engaged in cellular and tissue research.

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, published by Wiley, is a leading peer-reviewed journal dedicated to the field of experimental pathology. With an ISSN of 0959-9673 and E-ISSN 1365-2613, the journal has been a vital resource for researchers and professionals since its inception in 1990, covering a broad spectrum of topics within pathology, cell biology, and molecular biology. The journal's relevancy is underscored by its Q2 ranking in Pathology and Forensic Medicine and Q3 rankings in both Cell Biology and Molecular Biology, as of 2023, reflecting its significant contribution to the scientific community. Although it does not currently offer open access options, readers can benefit from its insightful research articles and reviews that guide advancements in diagnostic pathology and therapeutic strategies. As the journal continues to evolve, it remains committed to facilitating the exchange of innovative ideas and findings that drive progress in experimental pathology and related fields, making it an indispensable platform for scientists, clinicians, and students alike.

Adipocyte is a distinguished academic journal published by Taylor & Francis Inc., focusing on groundbreaking research within the realms of cell biology and histology. With an impact factor that reflects its importance, the journal has achieved a Q2 ranking in Cell Biology and a prestigious Q1 ranking in Histology for 2023, cementing its reputation as a leading resource for scientists and researchers in these fields. Since transitioning to Open Access in 2019, Adipocyte has fostered a wider dissemination of knowledge, enabling unrestricted access to a wealth of studies and reviews critical for advancing the understanding of adipose tissue biology. Located in the United Kingdom, with converged years spanning from 2013 to 2024, the journal serves as an essential platform for the exchange of innovative ideas and findings, supporting the academic community's efforts to unravel the complexities related to fat cells and their implications in health and disease.

BIOESSAYS, published by WILEY, is a leading academic journal dedicated to the dynamic fields of biochemistry, genetics, and molecular biology. With an impressive impact factor and recognized as a Q1 journal in its category for 2023, it ranks 49 out of 221 in the Scopus database, placing it within the 78th percentile among its peers. Since its inception in 1984, BIOESSAYS has served as a vital platform for researchers, professionals, and students, facilitating the dissemination of pivotal findings, innovative theories, and review articles that shape the current understanding of biological sciences. Although it does not offer open access, the journal remains key for those seeking to stay at the forefront of scientific discovery and discussion within this ever-evolving discipline. With its commitment to high-quality, peer-reviewed content, BIOESSAYS continues to influence future research directions and academic discourse.

TISSUE & CELL is a prominent academic journal, published by CHURCHILL LIVINGSTONE, that has been at the forefront of research in the fields of cell biology, developmental biology, and miscellaneous areas of medicine since its inception in 1969. With a strong focus on high-quality research, TISSUE & CELL has established itself within the academic community, holding a Q3 ranking in both Cell Biology and Developmental Biology, and a Q2 ranking in Medicine as of 2023. The journal aims to disseminate significant findings that contribute to the understanding of tissue structure and function, helping to bridge the gap between basic biological research and clinical applications. While it operates on a subscription basis and does not currently offer Open Access options, the journal remains a vital resource for researchers, professionals, and students interested in cutting-edge developments in the biological sciences. The journal's address is located in the scenic city of Edinburgh, further establishing its academic heritage in the United Kingdom.

CELLULAR & MOLECULAR BIOLOGY LETTERS, published by BMC, is a premier open-access journal dedicated to disseminating high-quality research in the fields of Biochemistry, Cell Biology, and Molecular Biology. Established in 1996, the journal has emerged as a leader in its domain, boasting an impressive Q1 ranking across three critical categories as of 2023, reflecting its significant impact within the scientific community. With an ISSN of 1425-8153 and an E-ISSN of 1689-1392, it offers accessible research findings to a global audience, having been open access since 2013. Situated in the United Kingdom, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, the journal continues to serve as a vital resource for researchers, professionals, and students, contributing to advancements in the understanding of cellular and molecular processes. By providing a platform for original research, reviews, and short communications, CELLULAR & MOLECULAR BIOLOGY LETTERS plays a crucial role in fostering dialogue and collaboration within the scientific community.